Merrimack Pharma Has Returned 17.8% Since SmarTrend Recommendation (MACK)

SmarTrend identified a Downtrend for Merrimack Pharma (NASDAQ:MACK) on December 6th, 2017 at $10.55. In approximately 6 months, Merrimack Pharma has returned 17.80% as of today's recent price of...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.